Glucose Monitoring Global Market is estimated to be worth $33,886.4 million by 2029

IQ4I Research & Consultancy published a new report on “Glucose Monitoring Global Market – Forecast To 2029” 


The Glucose Monitoring global market report mainly covers four segments namely product, sample source, end-users and geography. These segments are further segmented as follows:

Glucose Monitoring Global Market, By Products:

      Glucose monitoring products Market:

  • Invasive products
    • Self glucose monitoring products
  • Blood glucose meter
  • Blood glucose testing strips
  • Lancets & others
  • Sensors/ receiver
  • Transmitter
  • Non-Invasive products
  • Lab-based glucose monitoring products


Glucose Monitoring Global Market, by Sample Source:

  • Blood 
  • Urine
  • Others

Glucose Monitoring Global Market, based on end-user:

  • Hospitals
  • Private Clinics
  • Home care
  • Ambulatory settings


Glucose Monitoring Global Market, by Geography:

  • North America (U.S. and Rest of N.A.)
  • Europe (Germany, Italy, France and the Rest of E.U.)
  • Asia-Pacific (Japan, China, India, and Rest of APAC)
  • Rest of World (Brazil, Middle East & others and Rest of Latin America)


Each segment of this report offers market values for its sub-segments and geographies as well. It also provides market dynamics with respect to drivers, restraints, opportunities, and the performance of major key players.

According to IQ4I Research, the glucose monitoring global market is expected to grow at high double digit CAGR from 2022 to 2029 to reach $33,886.4 million by 2029.

Factors such as the global rise in the prevalence of diabetes, increasing demand for less minimally invasive or non-invasive and point-of-care devices, increasing R&D investments are driving the market growth, whereas, the growing diffusion of smart devices and digital platforms increasing compliance and management of diabetes is creating opportunities in the coming years. The high cost of the products, frequent product recalls and inadequate reimbursement is restraining the market growth. The stringent regulations, privacy concerns and safety issues are threats for the market growth.

The report covers business intelligence information of the glucose monitoring market segments based on product, sample source, end-users, and geography. Report contains market share analysis for overall glucose monitoring global market, self glucose monitoring, continuous glucose monitoring and regional SMBG and CGM market, revenue forecast of glucose monitoring global market and strategic analysis of each sub-segment with respect to segmental growth trends, identification of major market trends, Porter's model and factors driving and restraining glucose monitoring products market growth, analysis of the opportunities for stakeholders by identifying the high-growth segments of the market, analyzing funding and patent filing trend to assess innovation activities, identification of key technology developments and innovations driving the market, profiles of major players in the glucose monitoring market and analysis of their product offerings, financial revenue, business strategies, SWOTs and market shares, price analysis of glucose monitoring monitors, strips, sensors and transmitters, market penetration calculation based on regions and country wise

Major players in the Glucose monitoring market include Abbott Laboratories (U.S.), Dexcom (U.S.), Roche (Switzerland), LifeScan (U.S.), Medtronic, Inc. (Ireland), PHC Holding (Ascensia) (Japan), Sinocare (China), Arkray (Japan), Bio-Rad Laboratories (U.S.), and i-Sens, Inc., (South Korea), etc.